Ebola Spreads in Congo and Uganda, Over 130 Dead
The outbreak is driven by the rare Bundibugyo strain, which has no approved vaccine or treatment, and cases have already been confirmed in Uganda's capital, Kampala.
- By 11 June, DR Congo had reported roughly 676 confirmed cases and 136 deaths, while Uganda recorded 19 cases and 2 deaths.
- The outbreak is caused by the Bundibugyo strain, for which there is no approved vaccine or specific treatment.
- The World Health Organization declared a public health emergency of international concern back on 16 May.
- Most Ugandan cases with a known location have been registered in the capital, Kampala.
An outbreak that had spread for months across the eastern provinces of the Democratic Republic of Congo has now crossed an international border and reached Kampala, Uganda’s capital of more than 1.5 million people. For Serbia, whose diaspora and business circles increasingly travel toward East Africa, this is not a distant story. The public health emergency of international concern that the World Health Organization declared on 16 May means that surveillance measures at borders and airports are tightening across Europe’s gateways as well, including the connecting flights that link Belgrade with the wider region.
According to the latest figures, by 11 June DR Congo had reported roughly 676 confirmed cases and 136 deaths, placing this among the more serious outbreaks of the past decade. Uganda has so far recorded 19 confirmed cases and two deaths, but a worrying detail is that most patients with a known location have been registered in Kampala itself, a dense urban setting in which the virus can spread far faster than in rural areas.
Why is this strain so dangerous?
The main reason for alarm lies in the nature of the pathogen itself. The outbreak is caused by the Bundibugyo strain, one of the rarer variants of the Ebola virus, for which there is currently neither an approved vaccine nor a registered specific treatment. That is a fundamental difference from earlier outbreaks driven by the Zaire strain, where medical teams could reach for already licensed vaccines and monoclonal antibodies and bring transmission under control relatively quickly.
Without those tools, the response for now relies on classic epidemiological measures: isolating patients, tracing contacts, conducting safe burials, and strictly protecting health workers, who in every Ebola outbreak rank among the most exposed groups. Any failure in this chain, especially in crowded city districts, could trigger a new wave of infection.
The Africa Centres for Disease Control and Prevention and the World Health Organization have therefore launched a continental preparedness plan worth more than 500 million dollars, aimed at strengthening laboratories, training staff, and improving logistics in countries bordering the hot zones. At the same time, funding has been announced for several vaccine candidates targeting this strain, an admission that the medical community is facing an empty arsenal here.
What does this mean for Europe and Serbia?
The risk of direct transmission to Europe remains low, though not negligible. The experience of the 2014 West African outbreak showed that the virus can reach distant continents by air through individual travelers, and that timely detection at points of entry sharply reduces the damage. European health agencies have already raised their level of surveillance, and procedures for reporting suspected cases are active even in countries with no direct flights to the affected region.
For Serbian citizens traveling to East Africa, official advice comes down to caution: avoid contact with the sick, maintain consistent hygiene, and report any fever after returning home. The next few weeks will be decisive in judging whether Kampala remains a contained point or becomes a new epicenter. Are you following how this outbreak unfolds, and do you think the world has learned the lessons of previous crises?
